These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23085226)

  • 1. Proteomic analysis of endothelial cell secretome: a means of studying the pleiotropic effects of Hmg-CoA reductase inhibitors.
    Brioschi M; Lento S; Tremoli E; Banfi C
    J Proteomics; 2013 Jan; 78():346-61. PubMed ID: 23085226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of DKK-1 as a novel mediator of statin effects in human endothelial cells.
    Pontremoli M; Brioschi M; Baetta R; Ghilardi S; Banfi C
    Sci Rep; 2018 Nov; 8(1):16671. PubMed ID: 30420710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technological advances and proteomic applications in drug discovery and target deconvolution: identification of the pleiotropic effects of statins.
    Banfi C; Baetta R; Gianazza E; Tremoli E
    Drug Discov Today; 2017 Jun; 22(6):848-869. PubMed ID: 28284830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.
    Arnaud C; Mach F
    Arch Mal Coeur Vaiss; 2005 Jun; 98(6):661-6. PubMed ID: 16007821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
    Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
    J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells.
    Huang B; Wu CH; Li FA; Liang SS; Shieh YH; Wang LD
    Kaohsiung J Med Sci; 2013 Jul; 29(7):347-52. PubMed ID: 23768697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics to display lovastatin-induced protein and pathway regulation in rat liver.
    Steiner S; Gatlin CL; Lennon JJ; McGrath AM; Aponte AM; Makusky AJ; Rohrs MC; Anderson NL
    Electrophoresis; 2000 Jun; 21(11):2129-37. PubMed ID: 10892724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of HMG-CoA reductase inhibitors on leptin-induced endothelial cell proliferation, migration, and capillary-like tube formation.
    Burgazli KM; Stein NI; Mericliler M; Parahuleva M; Erdogan A
    Postgrad Med; 2014 May; 126(3):231-8. PubMed ID: 24918807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic effects of statins and related pharmacological experimental approaches.
    Alegret M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of endothelial lipid rafts reveals a novel role of statins in antioxidation.
    Gu MX; Fu Y; Sun XL; Ding YZ; Li CH; Pang W; Pan S; Zhu Y
    J Proteome Res; 2012 Apr; 11(4):2365-73. PubMed ID: 22428589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
    Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
    Mason RP; Walter MF; Jacob RF
    Circulation; 2004 Jun; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
    Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
    Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional expression of human HMG-CoA reductase in Saccharomyces cerevisiae: a system to analyse normal and mutated versions of the enzyme in the context of statin treatment.
    Wysocka-Kapcinska M; Lutyk-Nadolska J; Kiliszek M; Plochocka D; Maciag M; Leszczynska A; Rytka J; Burzynska B
    J Appl Microbiol; 2009 Mar; 106(3):895-902. PubMed ID: 19187128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG CoA reductase inhibition modulates VEGF-induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylation.
    Zeng L; Xu H; Chew TL; Eng E; Sadeghi MM; Adler S; Kanwar YS; Danesh FR
    FASEB J; 2005 Nov; 19(13):1845-7. PubMed ID: 16160062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation.
    Gelosa P; Cimino M; Pignieri A; Tremoli E; Guerrini U; Sironi L
    Vasc Health Risk Manag; 2007; 3(5):567-77. PubMed ID: 18078008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.